NCT04317794 - Observational, Postmarketing Surveillance Study of Spinraza Injection (Nusinersen Sodium) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 2, 2019

Primary Completion Date

February 5, 2027

Study Completion Date

February 5, 2027

Conditions

Muscular Atrophy, Spinal

Interventions

DRUG

Nusinersen Sodium Injection

Administered as specified in the treatment arm.

Trial Locations (16)

Pusan Natioanl University Hospital, Busan

Samsung Changwon Hospital, Changwon

Chungbuk National University Hospital, Cheongju-si

Kyungpook National University Hospital, Daegu

Yeungnam University Hospital, Daegu

Chungnam National University Hospital, Daejeon

Chonnam National University Hospital, Gwangju

Chonbuk National University Hospital, Jeonju

Asan Medical Center, Seoul

Korea university Anam Hospital, Seoul

Korea University Guro Hospital, Seoul

Samsung Medical Center, Seoul

Seoul Natioanl University Hospital, Seoul

Severance Hospital, Yonsei University Health System, Seoul

Pusan National University Yangsan Hospital, Yangsan

Severance Hospital, Seoul